Tocilizumab, Adipokines and Severe Complications of COVID-19

Detalles Bibliográficos
Autores principales: Fioravanti, Antonella, Porcelli, Brunetta, Terzuoli, Lucia, Bacarelli, Maria Romana, Tenti, Sara, Cheleschi, Sara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2020
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7357265/
https://www.ncbi.nlm.nih.gov/pubmed/32661912
http://dx.doi.org/10.1007/s40261-020-00950-2
_version_ 1783558656675020800
author Fioravanti, Antonella
Porcelli, Brunetta
Terzuoli, Lucia
Bacarelli, Maria Romana
Tenti, Sara
Cheleschi, Sara
author_facet Fioravanti, Antonella
Porcelli, Brunetta
Terzuoli, Lucia
Bacarelli, Maria Romana
Tenti, Sara
Cheleschi, Sara
author_sort Fioravanti, Antonella
collection PubMed
description
format Online
Article
Text
id pubmed-7357265
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-73572652020-07-13 Tocilizumab, Adipokines and Severe Complications of COVID-19 Fioravanti, Antonella Porcelli, Brunetta Terzuoli, Lucia Bacarelli, Maria Romana Tenti, Sara Cheleschi, Sara Clin Drug Investig Letter to the Editor Springer International Publishing 2020-07-13 2020 /pmc/articles/PMC7357265/ /pubmed/32661912 http://dx.doi.org/10.1007/s40261-020-00950-2 Text en © Springer Nature Switzerland AG 2020 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Letter to the Editor
Fioravanti, Antonella
Porcelli, Brunetta
Terzuoli, Lucia
Bacarelli, Maria Romana
Tenti, Sara
Cheleschi, Sara
Tocilizumab, Adipokines and Severe Complications of COVID-19
title Tocilizumab, Adipokines and Severe Complications of COVID-19
title_full Tocilizumab, Adipokines and Severe Complications of COVID-19
title_fullStr Tocilizumab, Adipokines and Severe Complications of COVID-19
title_full_unstemmed Tocilizumab, Adipokines and Severe Complications of COVID-19
title_short Tocilizumab, Adipokines and Severe Complications of COVID-19
title_sort tocilizumab, adipokines and severe complications of covid-19
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7357265/
https://www.ncbi.nlm.nih.gov/pubmed/32661912
http://dx.doi.org/10.1007/s40261-020-00950-2
work_keys_str_mv AT fioravantiantonella tocilizumabadipokinesandseverecomplicationsofcovid19
AT porcellibrunetta tocilizumabadipokinesandseverecomplicationsofcovid19
AT terzuolilucia tocilizumabadipokinesandseverecomplicationsofcovid19
AT bacarellimariaromana tocilizumabadipokinesandseverecomplicationsofcovid19
AT tentisara tocilizumabadipokinesandseverecomplicationsofcovid19
AT cheleschisara tocilizumabadipokinesandseverecomplicationsofcovid19

Ejemplares similares